Assessment of pulmonary fibrosis induced by paraquat using Al^18F-NODA-FAPI-04 PET/CT
暂无分享,去创建一个
[1] C. Qin,et al. Noninvasive Monitoring of Reparative Fibrosis after Myocardial Infarction in Rats Using 68Ga-FAPI-04 PET/CT. , 2022, Molecular pharmaceutics.
[2] P. Zhang,et al. Gallium-68-labeled fibroblast activation protein inhibitor PET in gastrointestinal cancer: insights into diagnosis and management , 2022, European Journal of Nuclear Medicine and Molecular Imaging.
[3] A. McMillan,et al. [68 Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity , 2022, European Journal of Nuclear Medicine and Molecular Imaging.
[4] Chunjing Yu,et al. Research progress on the role of fibroblast activation protein in diagnosis and treatment of cancer , 2022, Nuclear medicine communications.
[5] W. Cai,et al. Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond , 2022, European Journal of Nuclear Medicine and Molecular Imaging.
[6] Xing Zhou,et al. FAPI-04 PET/CT Using [18F]AlF Labeling Strategy: Automatic Synthesis, Quality Control, and In Vivo Assessment in Patient , 2021, Frontiers in Oncology.
[7] G. Schett,et al. 68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study. , 2021, The Lancet. Rheumatology.
[8] Yue Chen,et al. Value of [68Ga]Ga-FAPI-04 imaging in the diagnosis of renal fibrosis , 2021, European Journal of Nuclear Medicine and Molecular Imaging.
[9] Nan Li,et al. Clinical translational evaluation of Al18F-NOTA-FAPI for fibroblast activation protein-targeted tumour imaging , 2021, European Journal of Nuclear Medicine and Molecular Imaging.
[10] B. Hutton,et al. Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF) , 2018, European Journal of Nuclear Medicine and Molecular Imaging.
[11] Baishen Sun,et al. [Paraquat poisoning mechanism and its clinical treatment progress]. , 2017, Zhonghua wei zhong bing ji jiu yi xue.
[12] K. Togashi,et al. 18F-FDG Uptake in Less Affected Lung Field Provides Prognostic Stratification in Patients with Interstitial Lung Disease , 2016, The Journal of Nuclear Medicine.
[13] B. Sun,et al. Advances in the mechanism of paraquat-induced pulmonary injury. , 2016, European review for medical and pharmacological sciences.
[14] J. Connett,et al. Fibrotic extracellular matrix activates a profibrotic positive feedback loop. , 2014, The Journal of clinical investigation.
[15] B. Hutton,et al. Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[16] E. Puré,et al. Fibroblast activation protein in remodeling tissues. , 2012, Current molecular medicine.
[17] T. Wynn,et al. Mechanisms of fibrosis: therapeutic translation for fibrotic disease , 2012, Nature Medicine.
[18] J. Duarte,et al. Paraquat Poisonings: Mechanisms of Lung Toxicity, Clinical Features, and Treatment , 2008, Critical reviews in toxicology.
[19] E. Puré,et al. Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis. , 2006, Human pathology.